Search results
Adar Poonawalla (born 14 January 1981) is an Indian businessman. He is the chief executive officer of Serum Institute of India and Chairman of Poonawalla Fincorp. His father is Cyrus Poonawalla, founder of the Serum Institute of India.
Aug 20, 2023 · Adar Poonawalla is the Chief Executive Officer (CEO) of the Serum Institute of India (SII), a private family-owned business founded in 1966 by his father Dr. Cyrus Poonawalla. SII is the world’s largest vaccine manufacturer by the number of doses produced and sold a year (1.5bn).
Nov 12, 2020 · When the coronavirus pandemic broke out earlier this year, Adar Poonawalla, CEO of Serum Institute of India, the world’s largest vaccine maker by number of doses produced and sold, weighed...
Feb 3, 2022 · Adar Poonawalla is now busy diversifying it His father built a vaccine empire. The CEO of Serum Institute of India is finding newer frontiers to invest the family wealth.
May 17, 2024 · Adar Poonawalla is the Chief Executive Officer (CEO) of the Serum Institute of India (SII), a private family-owned business founded in 1966 by his father Dr. Cyrus Poonawalla. SII is the world’s largest vaccine manufacturer by the number of doses produced and sold a year (1.5bn).
Nov 2, 2021 · Adar Poonawalla — the CEO of Serum Institute of India (SII), the world’s largest vaccine maker — pumped hundreds of millions of dollars into his Indian manufacturing facility and committed...
Mar 7, 2022 · Adar Poonawalla can easily be termed as the poster boy of India’s vaccination drive. Rising to the challenge posed by the emergence of the Covid-19 pandemic, the Chief Executive of Serum...
Sep 15, 2021 · From the beginning of the pandemic, Adar Poonawalla sought to meet the moment. His company, the Serum Institute of India, was already the world’s largest vaccine maker when he promised 1.1 ...
From the beginning of the pandemic, Adar Poonawalla sought to meet the moment. His company, the Serum Institute of India, was already the world’s largest vaccine maker when he promised 1.1...
Nov 22, 2018 · Adar Poonawalla: Improving access to vaccines. CEO of the ₹4,837 crore by revenue Serum Institute of India, is looking to grow the low cost, high volume vaccine-maker to ₹10,000 crore by 2022....
